Next Article in Journal
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs
Next Article in Special Issue
Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution
Previous Article in Journal
Antimicrobial Stewardship and Urinary Tract Infections
Previous Article in Special Issue
Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects
Article Menu

Export Article

Open AccessReview
Antibiotics 2014, 3(2), 193-215;

β-Lactam Antibiotics Renaissance

ISOF-CNR Department of Chemistry "G. Ciamician", Via Selmi, 2 I-40126 Bologna, Italy
Allecra Therapeutics SAS, 13, rue de Village-Neuf, F-68300 St-Louis, France
Authors to whom correspondence should be addressed.
Received: 5 March 2014 / Revised: 30 April 2014 / Accepted: 4 May 2014 / Published: 9 May 2014
(This article belongs to the Special Issue Mechanisms of Antibiotic Resistance)
Full-Text   |   PDF [1041 KB, uploaded 9 May 2014]   |  


Since the 1940s β-lactam antibiotics have been used to treat bacterial infections. However, emergence and dissemination of β-lactam resistance has reached the point where many marketed β-lactams no longer are clinically effective. The increasing prevalence of multidrug-resistant bacteria and the progressive withdrawal of pharmaceutical companies from antibiotic research have evoked a strong reaction from health authorities, who have implemented initiatives to encourage the discovery of new antibacterials. Despite this gloomy scenario, several novel β-lactam antibiotics and β-lactamase inhibitors have recently progressed into clinical trials, and many more such compounds are being investigated. Here we seek to provide highlights of recent developments relating to the discovery of novel β-lactam antibiotics and β-lactamase inhibitors. View Full-Text
Keywords: β-lactam antibiotics; β-lactamase inhibitors; bacterial infections β-lactam antibiotics; β-lactamase inhibitors; bacterial infections

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Qin, W.; Panunzio, M.; Biondi, S. β-Lactam Antibiotics Renaissance. Antibiotics 2014, 3, 193-215.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top